Shijiazhuang Yiling Pharmaceutical Co Ltd (002603) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Shijiazhuang Yiling Pharmaceutical Co Ltd (002603) has a cash flow conversion efficiency ratio of 0.042x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥446.51 Million ≈ $65.34 Million USD) by net assets (CN¥10.70 Billion ≈ $1.57 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 002603 net asset quality score to measure how much of total assets are equity-financed.
Shijiazhuang Yiling Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2008–2025)
This chart illustrates how Shijiazhuang Yiling Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Shijiazhuang Yiling Pharmaceutical Co Lt (002603) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Shijiazhuang Yiling Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Shijiazhuang Yiling Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Hyundai Construction Equipment Co Ltd
KO:267270
|
0.044x |
|
Galenica Sante AG
SW:GALE
|
0.129x |
|
Guizhou Space Appliance Co Ltd
SHE:002025
|
-0.065x |
|
Post Holdings Inc
NYSE:POST
|
0.076x |
|
L&T Technology Services Limited
NSE:LTTS
|
0.076x |
|
PBF Energy Inc
NYSE:PBF
|
0.005x |
|
Synaptics Incorporated
NASDAQ:SYNA
|
0.016x |
|
Shanghai Oriental Pearl Media Co Ltd
SHG:600637
|
0.010x |
Annual Cash Flow Conversion Efficiency for Shijiazhuang Yiling Pharmaceutical Co Ltd (2008–2025)
The table below shows the annual cash flow conversion efficiency of Shijiazhuang Yiling Pharmaceutical Co Ltd from 2008 to 2025. For the full company profile with market capitalisation and key ratios, see market cap of Shijiazhuang Yiling Pharmaceutical Co Lt.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥10.98 Billion ≈ $1.61 Billion |
CN¥1.78 Billion ≈ $259.96 Million |
0.162x | +170.10% |
| 2024-12-31 | CN¥10.20 Billion ≈ $1.49 Billion |
CN¥611.01 Million ≈ $89.41 Million |
0.060x | +340.66% |
| 2023-12-31 | CN¥11.44 Billion ≈ $1.67 Billion |
CN¥155.46 Million ≈ $22.75 Million |
0.014x | -95.74% |
| 2022-12-31 | CN¥10.93 Billion ≈ $1.60 Billion |
CN¥3.49 Billion ≈ $510.37 Million |
0.319x | +447.55% |
| 2021-12-31 | CN¥9.07 Billion ≈ $1.33 Billion |
CN¥528.69 Million ≈ $77.36 Million |
0.058x | -67.22% |
| 2020-12-31 | CN¥8.92 Billion ≈ $1.31 Billion |
CN¥1.59 Billion ≈ $232.11 Million |
0.178x | +1950.92% |
| 2019-12-31 | CN¥7.95 Billion ≈ $1.16 Billion |
CN¥68.93 Million ≈ $10.09 Million |
0.009x | -9.41% |
| 2018-12-31 | CN¥7.56 Billion ≈ $1.11 Billion |
CN¥72.37 Million ≈ $10.59 Million |
0.010x | -40.65% |
| 2017-12-31 | CN¥7.11 Billion ≈ $1.04 Billion |
CN¥114.65 Million ≈ $16.78 Million |
0.016x | -86.60% |
| 2016-12-31 | CN¥5.33 Billion ≈ $780.36 Million |
CN¥641.45 Million ≈ $93.86 Million |
0.120x | +340.29% |
| 2015-12-31 | CN¥4.83 Billion ≈ $706.40 Million |
CN¥131.88 Million ≈ $19.30 Million |
0.027x | +13.93% |
| 2014-12-31 | CN¥4.42 Billion ≈ $646.31 Million |
CN¥105.90 Million ≈ $15.50 Million |
0.024x | +84.57% |
| 2013-12-31 | CN¥4.26 Billion ≈ $623.13 Million |
CN¥55.32 Million ≈ $8.10 Million |
0.013x | -28.77% |
| 2012-12-31 | CN¥3.84 Billion ≈ $562.64 Million |
CN¥70.13 Million ≈ $10.26 Million |
0.018x | +116.53% |
| 2011-12-31 | CN¥3.70 Billion ≈ $541.67 Million |
CN¥-408.49 Million ≈ $-59.77 Million |
-0.110x | -140.17% |
| 2010-12-31 | CN¥1.09 Billion ≈ $159.65 Million |
CN¥299.72 Million ≈ $43.86 Million |
0.275x | -31.75% |
| 2009-12-31 | CN¥790.55 Million ≈ $115.68 Million |
CN¥318.21 Million ≈ $46.56 Million |
0.403x | -7.30% |
| 2008-12-31 | CN¥484.03 Million ≈ $70.83 Million |
CN¥210.18 Million ≈ $30.76 Million |
0.434x | -- |
About Shijiazhuang Yiling Pharmaceutical Co Ltd
Shijiazhuang Yiling Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of traditional Chinese medicine in China and internationally. It offers dietary supplements, and healthy food and drinks; patent TCM products for respiratory health, cardiovascular disease, diabetes, mellitus, oncology, urologic disease, sleep-improving, and anti-aging; disinfection and pers… Read more